Vaccination with a genetically modified yeast strain of C. neoformans, known as H99γ, which produces IFN-γ, has been shown to induce protective immunity against cryptococcosis in mice that lack CD4+ T cells [105]. The gene discussed is IFNG; the disease is cryptococcosis.